Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
3.820
+0.060 (1.60%)
Jan 21, 2025, 4:00 PM EST - Market closed
Genenta Science Employees
Genenta Science had 14 employees as of December 31, 2023.
Employees
14
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$683,040
Market Cap
69.87M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
GNTA News
- 13 days ago - Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing - GlobeNewsWire
- 13 days ago - ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE - PRNewsWire
- 3 months ago - Genenta's CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective” - GlobeNewsWire
- 4 months ago - Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer - GlobeNewsWire
- 9 months ago - Genenta Welcomes New Directors John L. Cantello, Lauren H. - GlobeNewsWire
- 1 year ago - Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors - GlobeNewsWire
- 1 year ago - Genenta to Present at Upcoming Scientific and Investor Conferences - GlobeNewsWire
- 1 year ago - Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments - GlobeNewsWire